14, 15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds

14,15-cyclopranoandrostanes of the 19-norandrostane series of the formula (I)

• wherein R1 is a hydrogen atom, a hydroxy group, C1-10-alkyl, a C1-10-alkyloxy, a C1-15 acyloxy, a C4-15-aryloxy, a C7-15-aralkyloxy or a C7-15-alkylaryloxy group;
• R2 represents a hydrogen atom, a hydroxy group, a C1-10 alkyl group, a C1-10 acyl group, a C1-10 acyloxy group, a C6-15 aryl group, a C7-15 aralkyl group, a C7-15 alkylaryl group, a —(CH2)nCH2Y group with n=0, 1 or 2 and Y representing a halogen atom or a pseudohalogen;
• a (CH2)mCH═CH(CH2)pR6 group with m=0,1, 2 or 3 and p=0, 1 or 2 and R6 representing a hydrogen atom, a C1-10-alkyl group, a C6-15 aryl group, a C7-15 aralkyl group, a C7-15 alkylaryl group, a hydroxyl group, a C1-10 alkyloxy group, a C1-10 acyloxy group;
• a —(CH2)oC≡CR7 group with o=0, 1 or 2 and R7 representing a hydrogen atom, a halogen atom, a C1-10 alkyl group, a C6-15 aryl group, a C7-15 aralkyl group, a C7-15 alkylaryl group or a C1-10 acyl group;
• or
• R1 and R2 together represent a keto group, a methylene group, a difluoromethylene group or, with inclusion of C-17, a spirooxirane or a 2,2-dimethyl-1,3-dioxolane;
• R3 represents a hydrogen atom or an α-C1-10 alkyl group or β-C1-10 alkyl group;
• R4 represents a halogen atom, a pseudohalogen, a hydroxy group or a perfluoroalkyl group;
• R5 represents a C1-4 alkyl group,
• wherein an α-cyclopropane or a β-cyclopropane group is between C-14 and C-15;
• and wherein optionally a 9,10-double bond is present and optionally an 11,12-double bond is present,
• with the proviso that, if both the 9,10-double bond and the 11,12-double bond are present or if only the 11,12-double bond is present, then R4 can be a hydrogen atom in addition to said halogen atom, said pseudohalogen, said hydroxy group or said perfluoroalkyl group;
• and
• with the further proviso that, if R5 is a methyl group, then R4 can be a hydrogen atom in addition to said halogen atom, said pseudohalogen, said hydroxy group or said perfluoroalkyl group;
• or pharmaceutically tolerated salts thereof.